Sarah Power

Nov 5, 2024 | pinsentmasons.com | Karen Symms Gallagher |Sarah Power |Alasdair Weir |Aleesha Way

This follows the Supreme Court recalibration of the test for preliminary injunctive relief in 2019 in another pharmaceutical patent case, MSD v Clonmel. Read more on this topic Patent litigation in Ireland: Irish patent system Patent litigation in Ireland: pre-action steps and initiating proceedingsSection 40 and 41 of the Patents Act 1992 (the Irish Patents Act) govern direct and indirect infringement respectively.

Jul 18, 2024 | worldtrademarkreview.com | Sarah Power

European Union Legal updates: case law analysis and intelligence

Jul 3, 2024 | pinsentmasons.com | Jane Bourke |Sarah Power |Attila Bangha-Szabo

On 26 April 2023, the European Commission put forward a legislative package aimed at revising and replacing existing pharmaceutical legislation. Among the objectives is the continued offering of an attractive and innovation friendly framework for research and development and production of medicines in the EU. Included in the package is a draft Directive (2023/0132 (COD)) which proposes to revise the Bolar exemption with the aim of harmonising the application of the exemption across member states.

Jun 28, 2024 | pinsentmasons.com | Maureen Daly |Sarah Power |Alison Rankine

Irish businesses should review their existing policies and create an inventory of any AI systems they are using or deploying in preparation for the incoming EU AI Act. The EU AI Act, dubbed the world’s first AI law, is set to come into force in the EU in the coming month. Ireland is one of several EU member states to have kick-started the national process to implement the new EU-wide regime.